CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism
- PMID: 27178705
- PMCID: PMC4909560
- DOI: 10.1212/WNL.0000000000002766
CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism
Abstract
Objective: To examine the association between cerebral folate deficiency and autism, this study examined CSF 5-methyltetrahydrofolate (5-MTHF) concentrations in a group of young children with autism, investigated the natural variation in CSF 5-MTHF over time, and assessed the relationship between CSF 5-MTHF and symptoms.
Methods: CSF was collected from 67 children with a diagnosis of DSM-IV-TR autistic disorder (age, mean ± SD 43 ± 11 months), with a second CSF sample obtained 1-3 years later on 31 of these subjects (time to follow-up, 30 ± 8 months).
Results: At time 1, 7% (5/67) of participants had 5-MTHF <40 nmol/L. At follow-up, 23% (7/31) of participants had 5-MTHF <40 nmol/L (only one of whom had been low at time 1). A moderate correlation with a very wide confidence interval (CI) was observed between time 1 and time 2 CSF 5-MTHF measurements (Pearson r[p] = 0.38 [0.04]; 95% CI 0.02-0.64). Neither the CSF 5-MTHF levels nor changes over time correlated with the clinical features of autism.
Conclusions: CSF 5-MTHF levels vary significantly over time in an unpredictable fashion and do not show a significant relationship to typical clinical features of autism. Reduced CSF 5-MTHF levels are a nonspecific finding in autism. Our data do not support the use of lumbar puncture for assessment of CSF 5-MTHF in autism.
Trial registration: ClinicalTrials.gov NCT00298246.
© 2016 American Academy of Neurology.
Figures

Comment in
-
Letter re: CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism.Neurology. 2017 Jan 3;88(1):110-111. doi: 10.1212/WNL.0000000000003474. Neurology. 2017. PMID: 28025401 No abstract available.
-
Author response: CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism.Neurology. 2017 Jan 3;88(1):111. doi: 10.1212/WNL.0000000000003475. Neurology. 2017. PMID: 28025402 No abstract available.
Similar articles
-
Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects.Arch Neurol. 2011 May;68(5):615-21. doi: 10.1001/archneurol.2011.80. Arch Neurol. 2011. PMID: 21555636
-
Levels of 5-methyltetrahydrofolate and ascorbic acid in cerebrospinal fluid are correlated: implications for the accelerated degradation of folate by reactive oxygen species.Neurochem Int. 2013 Dec;63(8):750-5. doi: 10.1016/j.neuint.2013.10.002. Epub 2013 Oct 15. Neurochem Int. 2013. PMID: 24140430
-
Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations.Mol Genet Metab. 2008 Nov;95(3):127-32. doi: 10.1016/j.ymgme.2008.07.004. Epub 2008 Aug 22. Mol Genet Metab. 2008. PMID: 18722797
-
Folate, folic acid and 5-methyltetrahydrofolate are not the same thing.Xenobiotica. 2014 May;44(5):480-8. doi: 10.3109/00498254.2013.845705. Epub 2014 Feb 4. Xenobiotica. 2014. PMID: 24494987 Review.
-
Is there a multidisciplinary role for 5-methyltetrahydrofolate? The obstetric evidence in perspective.Eur Rev Med Pharmacol Sci. 2024 Jul;28(13):3934-3945. doi: 10.26355/eurrev_202407_36526. Eur Rev Med Pharmacol Sci. 2024. PMID: 39012232 Review.
Cited by
-
Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS.Sci Rep. 2018 Nov 5;8(1):16334. doi: 10.1038/s41598-018-34642-x. Sci Rep. 2018. PMID: 30397248 Free PMC article.
-
Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial.Child Psychiatry Hum Dev. 2021 Oct;52(5):928-938. doi: 10.1007/s10578-020-01072-8. Epub 2020 Oct 7. Child Psychiatry Hum Dev. 2021. PMID: 33029705 Clinical Trial.
-
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.Mol Diagn Ther. 2018 Oct;22(5):571-593. doi: 10.1007/s40291-018-0352-x. Mol Diagn Ther. 2018. PMID: 30039193 Free PMC article. Review.
-
Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.J Pers Med. 2021 Nov 3;11(11):1141. doi: 10.3390/jpm11111141. J Pers Med. 2021. PMID: 34834493 Free PMC article. Review.
-
Folic Acid and Autism: A Systematic Review of the Current State of Knowledge.Cells. 2021 Aug 3;10(8):1976. doi: 10.3390/cells10081976. Cells. 2021. PMID: 34440744 Free PMC article.
References
-
- Djukic A. Folate-responsive neurologic diseases. Pediatr Neurol 2007;37:387–397. - PubMed
-
- Hyland K, Shoffner J, Heales SJ. Cerebral folate deficiency. J Inherit Metab Dis 2010;33:563–570. - PubMed
-
- Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004;46:843–851. - PubMed
-
- Pérez-Duenas B, Ormazábal A, Toma C, et al. . Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects. Arch Neurol 2011;68:615–621. - PubMed
-
- Ho PI, Ashline D, Dhitavat S, et al. . Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis 2003;14:32–42. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical